Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Ascorbic acid reduces accumulation of (/sup 3/H)spiperone in mouse striatum in vivo

Journal Article · · Proc. Soc. Exp. Biol. Med.; (United States)
(/sup 3/H)Spiperone was administered to mice. In agreement with other published reports, 2 hr later the accumulation of tritium was three to four times greater in the corpus striatum than in the cerebellum. Ascorbic acid (100, 1000, 2000 mg/kg, ip, 30 min) reduced the 2-hr accumulation in the corpus striatum 16, 42, and 63%, respectively, with only the highest does producing any significant reduction in the cerebellum. The effect was still evident in striatum 18 hr after a single dose of 1000 mg/kg. Striatal minces taken from mice treated 1 or 2 hr earlier with ascorbic acid showed no reduction in (/sup 3/H)spiperone binding. However, preincubation of striatal minces for 2 hr with ascorbic acid (10/sup -3/ M) produced an 82% reduction in specific binding while not having any effect on nonspecific binding. While it cannot be certain that the reduction of striatal (/sup 3/H) spiperone concentrations after ascorbic acid in vivo was not a result of some nonspecific alteration in the pharmacokinetics of (/sup 3/H)spiperone, the in vitro observation strongly suggests that it resulted from an alteration of binding characteristics at the receptor level.
Research Organization:
Baylor College of Dentistry, Dallas, TX (USA)
OSTI ID:
5409899
Journal Information:
Proc. Soc. Exp. Biol. Med.; (United States), Journal Name: Proc. Soc. Exp. Biol. Med.; (United States) Vol. 186:1; ISSN PSEBA
Country of Publication:
United States
Language:
English